Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has inaugurated its new office in Suwon, Korea. The office relocation reflects Avantor’s continued investment in the Asia Pacific region and its commitment to providing a modern, collaborative workspace for associates.
The new office space is designed to enhance collaboration, drive innovation and build closer customer relationships. With this relocation, Avantor is better positioned to continue serving the fast-evolving Korean market while advancing its global mission of setting science in motion to create a better world.
Company leaders, including Benoit Gourdier, Executive Vice President, Biopharma Production Segment; Christophe Couturier, Executive Vice President, AMEA Region; and Narayana Rao Rapolu, Senior Vice President, Global Bioprocessing Commercial, joined the office opening, underscoring Korea’s strategic importance within Avantor’s global operations.
“Establishing our new office in Suwon is a strategic move that strengthens our presence in one of Asia’s most dynamic markets,” said Christophe Couturier, Executive Vice President, AMEA Region. “This space enables our teams to stay closely connected to our customers’ evolving needs and reinforces our ability to deliver tailored solutions that drive meaningful outcomes in the Asia Pacific region.”
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Avantor Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, was recognized with two prestigious awards at the recent Asia-Pacific Biopharma Excellence Awards (ABEA) 2025. The recognition underscores Avantor’s commitment to providing high-quality biopharma manufacturing solutions, addressing logistics challenges and optimizing supply chain.
Specifically, Avantor was recognized for the ABEA:
Best Bioprocessing Supplier Award: Single Use Systems
Best Bioprocessing Supplier Award: Chromatography
Single-use solutions enhance flexibility and speed in biopharma manufacturing. As the only open-architecture provider, Avantor offers end-to-end design, manufacturing, and logistics support worldwide. With a diverse portfolio of chromatography resins and advanced production technologies, these solutions enable the rapid and scalable delivery of high-quality therapies.
Narayana Rao Rapolu, VP & GM, BPS AMEA, Avantor said, “We are honored by these two awards recognizing Avantor and our team’s contributions to advancing biomanufacturing. As biologics grow more complex, Avantor remains dedicated to providing innovative chromatography and single-use solutions that enhance flexibility, efficiency, and cost-effectiveness globally. Additionally, by leveraging our wide range of chromatography resins, process chemicals, and reagents, our application scientists, and customer support centers are able to provide total solutions that improve process efficiency.”
Rajesh Bhagwat, Director, Strategy & Marketing, BPS AMEA, Avantor said, “Avantor’s expertise in delivering customized, scalable solutions drives innovation in biopharmaceutical manufacturing. Our advanced chromatography resins, including PROchievA and J.T.Baker® Bakerbond®, provide unique selectivity for next-generation therapies across the Asia-Pacific region. This award reinforces our commitment to supporting customers at every stage, from small-scale development to large-scale production.”
Rajesh Bhagwat, Director, Strategy & Marketing, BPS AMEA, Avantor, receiving the Best Bioprocessing Supplier Award – Chromatography at ABEA 2025
Stephanie Chan, Head of Biopharma, SEA, Avantor, receiving the Best Bioprocessing Supplier Award – Single Use Systems at ABEA 2025
The Asia-Pacific Biopharma Excellence Awards (ABEA) recognizes exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill and finish experts, organizations and technologies. It celebrates outstanding achievements and innovations in the bioprocessing industry across the Asia Pacific region. The awards are judged by a panel of industry experts, and winners are selected based on their contributions to the advancement of the bioprocessing industry.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the esteemed Korea Biopharma Excellence Awards (KBEA) 2024. The KBEA event, held in conjunction with the 13th Annual Biologics Manufacturing Korea & 6th Vaccine World East Asia 2024 on 13-14, August 2024, underscores Avantor’s exceptional achievements in downstream processing and single-use systems, as well as its leadership as a biopharma supplier in Korea.
Left: Andrew Wong, Chief Executive Officer/General Manager of Shanghai Wotai Biotechnology, China Right: James Hwang, Head – Biopharma Applications, AMEA, Avantor
Avantor received the following awards:
Best Bioprocessing Supplier Award: Downstream Processing
Best Bioprocessing Supplier Award: Single Use Systems
Overall Biopharma Supplier of the Year
These accolades highlight Avantor’s commitment to excellence and innovation in bioprocessing. The “Best Bioprocessing Supplier Award: Downstream Processing” acknowledges Avantor’s products and solutions that enhance the efficiency and effectiveness of downstream processing in biopharmaceutical manufacturing. Supporting this success is Avantor’s Korea Innovation Customer Support Center (ICSC), which serves as a hub of scientific collaboration and innovation. The ICSC team collaborates closely with customers, offering services that help improve yields, reduce production costs, and ensure efficient production.
The “Best Bioprocessing Supplier Award: Single Use Systems” recognizes Avantor’s pioneering single-use solutions for strengthening production capabilities, streamlining operations, and improve scalability for biopharmaceutical companies. Notably, this marks the fourth consecutive year that Avantor has received the “Best Bioprocessing Supplier Award: Single Use Systems,” following wins in 2022, 2021, and 2020.
The “Overall Biopharma Supplier of the Year” award is a testament to Avantor’s comprehensive impact on the biopharma industry, reflecting the company’s dedication to providing high-quality products and services that drive advancements in biopharmaceutical research and production.
Jin Young Lee, Head, Biopharma, APAC, Avantor, expressed his gratitude for the recognition, stating, “We are incredibly honoured to receive these prestigious awards at the Korea Biopharma Excellence Awards 2024. These accolades underscore our relentless commitment to innovation and excellence in bioprocessing and reinforces our standing as a premier supplier in the biopharma industry. They are a testament to the hard work and dedication of our team in Korea, who strive to deliver solutions that enable our customers to deliver life-changing therapies to the patients who need them.”
James Hwang, Head of Biopharma Applications, AMEA, Avantor commented on the awards and said, “Receiving these awards is a testament to our relentless dedication to advancing bioprocessing capabilities. Our commitment to innovation is embodied in the work we do at the Korea Innovation Customer Support Center (ICSC). Our dedicated team of scientists and application experts at the ICSC help customers with process optimisation, troubleshooting, new product proof of concepts, and hands-on trainings to meet their evolving needs. These awards not only recognize our achievements but also highlight the importance of collaboration and customer-centricity in advancing the biopharma industry.”
Avantor’s recognition at the Korea Biopharma Excellence Awards 2024 follows its recent success at the Asia-Pacific Biopharma Excellence Awards 2024, where the company won five awards, further solidifying its leadership position in the biopharmaceutical industry.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visitavantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured five prestigious awards at the esteemed Asia-Pacific Biopharma Excellence Awards (ABEA) 2024. The ABEA event, held in conjunction with the 11th Annual Biologics Manufacturing Asia 2024, 8th BioLogistics World Asia 2024, and 2nd Annual Clinical Trials Festival Asia 2024, underscores Avantor’s exceptional achievements in bioprocessing, logistics, and supply chain management, as well as its leadership in the biopharma sector.
Avantor sweeps 5 Biopharma Award at the Asia Pacific Biopharma Excellence Awards 2024 in Singapore.(Right) Narayana Rao, Vice President and General Manager, Bioscience Production, Asia Middle-East Africa (AMEA), Avantor receiving the Bioprocessing Leadership Award
Avantor is honored with five ABEA awards, including three excellence recognitions and two individual accolades:
Overall Downstream Bioprocessing Supplier Award
Best Aseptic Fill-Finish and Packaging Supplier Award for Formulation Development
Best Bioprocessing Supplier Award for Single-use Systems
Bioprocessing Leadership Award presented to Narayana Rao, Vice President and General Manager, Bioscience Production, Asia Middle-East Africa (AMEA), Avantor
Supply Chain Management Lifetime Achievement Award conferred upon Yee Seng Ng, Vice President, Operations, Asia Middle-East Africa (AMEA), Avantor
Expressing gratitude for the recognition, Rao said, “We are honored to receive these awards, which represent our steadfast commitment to providing indispensable support to the biopharma industry across the AMEA region. I am proud of Avantor’s commitment to advancing manufacturing efficiency, cost-effectiveness, and quality while supporting our customers at every stage of their innovation lifecycle, from discovery to commercialization. I also would like to extend my sincere appreciation to Avantor for supporting the growth and development of our team.”
“These awards are a testament to the dedication and expertise of our Avantor team,” remarked Christophe Couturier, Executive Vice President of AMEA, Avantor. “At Avantor, we understand the critical importance of resilient and adaptable supply chains to enabling progress across the biopharma sector and we are committed to empowering our customers to optimize their bioprocessing operations.”
As a trusted global partner to the biopharma industry, Avantor supports customers across the AMEA region in navigating operational challenges such as productivity constraints providing unwavering support and driving innovation to accelerate life-changing innovation.
The Asia-Pacific Biopharma Excellence Awards (ABEA) recognizes exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill and finish experts, organizations and technologies. It celebrates outstanding achievements and innovations in the bioprocessing industry across the Asia Pacific region. The awards are judged by a panel of industry experts, and winners are selected based on their contributions to the advancement of the bioprocessing industry.
About Avantor®
Avantor®, a Fortune 500 company, is a leading life science tools company and global provider of mission-critical products and services to customers in the life sciences and advanced technology industries. From discovery to delivery, we work side-by-side with scientists around the world to enable breakthroughs in medicine, healthcare, and technology at scale. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, today inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory. The hub is a one-stop facility serving the needs of customers across Asia, Middle East, and Africa (AMEA), strengthening the region’s innovation and biopharma ecosystems.
Strategically located in Singapore, the hub enables quicker turnaround times and expedites customers’ access to raw materials that are essential in AMEA’s drug discovery and development whilst upholding stringent quality standards.
“At Avantor, we recognize the growing complexities around customer requirements and regulatory standards across AMEA’s biopharma industry,” said Christophe Couturier, Executive Vice President, AMEA. “By enhancing our regional capabilities through the launch of our Singapore Manufacturing and Distribution Hub, we tap into our legacy of serving the evolving needs of customers, demonstrating our commitment to advancing life-changing science.”
The inauguration ceremony today was officiated by Avantor executives, Christophe Couturier, and Narayana Rao, Vice President, Biopharma – AMEA, and the Singapore Economic Development Board (EDB), represented by Elaine Teo, Senior Vice President and Head, Investment Facilitation at EDB.
“Avantor’s latest expansion of its Singapore hub enhances the supply of key materials and services required by biopharma manufacturers in Singapore and the region. This strengthens supply chain resilience for businesses and enhances the competitiveness of Singapore’s biomedical sciences industry, an integral part of Singapore’s manufacturing sector. Avantor’s successive investments in Singapore demonstrate confidence in our manufacturing and supply chain capabilities. These expansions are in line with EDB’s commitment to work with businesses to deepen their footprint and create new job opportunities in Singapore,” said Elaine Teo, Senior Vice President, EDB.
Building onto Avantor’s 2022 investment, the integration of the current distribution hub with new manufacturing operations features cGMP suites, quality testing, warehousing of certified products, batch-to-batch traceability and customized palletization capabilities. These state-of-the-art facilities allow the hub to drive innovation and efficiency to address the immediate challenges in AMEA’s biopharma industry.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, has been honored with the Best Bioprocessing Supplier Award for Cell and Gene Therapy at the Biopharma Excellence Awards (BEA) India Edition 2023, organized by IMAPAC in Pune, India.
Ganesh Bade – Head of Biopharma India Middle East & Africa (IMEA), Avantor (right) receiving the accolade at the Awards ceremony.
Ganesh Bade, Head Biopharma India Middle East and Africa (IMEA) at Avantor, said, “Cell and gene therapy is considered a game-changer for the biopharma industry. But the real effort lies in supplying this life altering solution at a reasonable cost to those in need. With high purity production chemicals, sterile fluid transfer systems, cell culture components and excipient technologies, Avantor is advancing the scalability and manufacturability of viral vector production to cell and gene therapies.”
“One of the most revolutionary modalities rising in the biopharmaceutical sector is cell and gene therapies. Avantor offers a comprehensive range of bioprocessing solutions such as media and supplements, single-use technologies, and custom development services to help accelerate the development and commercialization of cell and gene therapies,” said Amit Sehgal, Managing Director, Avantor India. “With this award, we are renewing our commitment to make cell and gene therapy successful and supply it with greater efficacy and reduced risk.”
Avantor provides compliant materials in scalable formats and single-use solutions for viral vector, CAR-T and gene therapies manufacturing, that have the potential to help reduce contamination risk, improve resource efficiency and reduce labor and energy costs. As part of its regulatory support services, Avantor also helps customers navigate the complex regulatory landscape of cell and gene therapy development and commercialization.
The Best Bioprocessing Supplier in Chromatography award recognizes Avantor’s ongoing efforts to provide innovative chromatography solutions that enable biopharmaceutical manufacturers to optimize processes and enhance product quality. With over four decades of experience in bioprocessing, Avantor is committed to addressing the complex challenges of downstream chromatography by providing a comprehensive range of equipment, products and services.
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.
About Bioprocessing Excellence Awards (ABEA) India Edition 2023
The Biopharma Excellence Awards (BEA) India 2023 seeks to recognize exceptional biologics and vaccine experts, organizations and technologies that facilitate vaccine R&D and biologics manufacturing excellence at enhanced speed, reduced cost and superior quality. The BEA India Edition 2023 applauds extraordinary leaders & trendsetters of today and inspires the innovators of tomorrow.
Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, education, government and advanced technologies & applied materials industries, has been accorded the Best Bioprocessing Company for Chromatography at the Asia-Pacific Bioprocessing Excellence Awards 2023 (ABEA).
Narayana Rao Rapolu, Vice President – Biopharma AMEA and General Manager, SEAT (left) receiving the award from Dr Wei Kuang Chi (right) Distinguished Consultant, Development Center for Biotechnology
The award recognizes Avantor’s ongoing efforts to provide innovative chromatography solutions that enable biopharmaceutical manufacturers to optimize processes and enhance product quality. With over four decades of experience in bioprocessing, Avantor is committed to addressing the complex challenges of downstream chromatography by providing a comprehensive range of equipment, products and services.
“Chromatography is one of the most important components in enabling scientific breakthroughs and bringing promising biologics to market effectively. This award is a testament to our commitment to developing and delivering innovative solutions that help our customers optimize their bioprocessing operations,” said Narayana Rao Rapolu, Vice President – Biopharma AMEA and General Manager, South East Asia & Taiwan (SEAT) at Avantor. “Our chromatography solutions can play a critical role in supporting biopharmaceutical manufacturers’ acceleration of their drug development timelines and improving the quality of their products.”
“We are exceptionally proud to have been selected by the panel of industry experts and honored at this year’s ceremony as the Best Bioprocessing Company – Chromatography. Avantor’s chromatography solutions have demonstrated innovation and effectiveness in addressing the challenges faced by biopharmaceutical manufacturers, and we are excited to see the continued impact of these solutions in the industry,” said Christophe Couturier, Executive Vice President of Asia, Middle East & Africa.
About Avantor
Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn (www.linkedin.com/company/avantorinc/, Twitter (https://twitter.com/Avantor_News) and Facebook (www.facebook.com/Avantorinc/).
About Asia Pacific Bioprocessing Excellence Awards (ABEA)
The Asia-Pacific Bioprocessing Excellence Awards (ABEA) seeks to give recognition to exceptional Asian bioprocessing, biologistic, clinical trials and aseptic fill & finish experts, organizations and technologies over the past year. It celebrates outstanding achievements and innovations in the bioprocessing industry across the Asia Pacific region. The awards are judged by a panel of industry experts, and winners are selected based on their contributions to the advancement of the bioprocessing industry.
Avantor Foundation, Avantor’s philanthropic arm, committed financial resources to healthcare charitable organizations, HealthServe and SATA CommHealth, as part of the Foundation’s mission to provide healthcare to those in need.
The grants will offer much-needed support to communities who would otherwise be unable to receive quality medical care. By identifying community needs and addressing them through these grants, the Avantor Foundation is able to contribute to the advancement of healthcare in Singapore and the region.
“As we continue to create a better world, grants like this demonstrate our commitment to providing healthcare to those in need,” said Christophe Couturier, Executive Vice President, AMEA, Avantor and Board Member of the Avantor Foundation. “By working with SATA CommHealth and HealthServe, we want to connect and help communities, which deserve crucial assistance but are sometimes overlooked. The aid we are providing will address the critical unmet needs in healthcare and enable Science for Goodness, and ultimately create a lasting impact in our communities.”
SATA CommHealth, an organization which serves the community through the provision of subsidized care in their medical centers, will work with approximately 50 community and grassroots organizations to provide free health screenings for the elderly and less fortunate through regular check-ups and early medical intervention to prevent chronic or deadly diseases.
“We are truly grateful to receive this generous donation from the Avantor Foundation,” said Boon Khiang Chia, Director & Head of Strategic Partnerships & Branding, SATA CommHealth. “We will be able to facilitate collaboration with our community leaders and constituency representatives to effectively serve the healthcare needs of our beneficiaries, especially the elderly who are most vulnerable to poor health.”
The Avantor Foundation also has provided a grant to HealthServe, a medical NGO that advocates for the needs and wellbeing of vulnerable, low-wage migrant workers in Singapore. Their services include healthcare, counseling, casework, mental health support and social assistance for their beneficiaries. HealthServe will use this grant for a nurse-led chronic disease case management program that supports migrant workers in need of medical assistance.
Michael Cheah, Executive Director, HealthServe said, “Bringing healing and hope to migrant workers has always been a cause that is very close to our hearts. This contribution from the Avantor Foundation will allow us to offer customized care plans to these workers in need of medical assistance and deliver better care outcomes for them in the long term.”
About Avantor
Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.
As the philanthropic arm of Avantor, the Avantor Foundation’s mission is to create a better world by advancing science education and providing healthcare to those in need. Since 2009, the Avantor Foundation has been making a difference in the science community by supporting organizations aligned to its mission. Learn more at www.avantorsciences.com/pages/en/avantor-foundation.
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, acquired awards for the best company in upstream processing and single-use solutions at the Biologics Manufacturing Korea (BMK) 2022 conference.
Sang Kyu Lee, Representative Director – Avantor Korea/Japan (Left), James Hwang, Head of Application, Asia, Middle East & Africa – Biopharma after receiving the Awards for Best Company in Single-use Solutions and Upstream Processing at BMK 2022
This is the second consecutive year that Avantor has been recognized for its upstream processing capabilities, a testament to its ongoing investment and innovations including development of high-purity raw materials, reagents and differentiated cell culture processes. In single-use solutions, Avantor received the best company award for the third consecutive year. Avantor was recognized for strengthening production capabilities and establishing an optimized supply chain in collaboration with global partners to respond to the growing need of biopharmaceutical manufacturers for single-use solutions.
Narayana Rao Rapolu, Vice President, Biopharma Asia Middle East & Africa for Avantor said, “Avantor’s single-use solutions enable biomanufacturers to bring new therapies to market faster and improve global health. Our local teams have expertise and experience across multiple processes that drive therapies forward from prototype development to system design, production and delivery. We offer the choice, agility and speed needed to support the evolving life-sciences market in Korea and across the region.”
Sang Kyu Lee, Representative Director for Avantor Korea & Japan said, “We are proud to be recognized for Avantor’s ability to support biopharmaceutical manufacturers through our comprehensive product portfolio and customer-driven production technologies. We continue to introduce innovations that allow life-changing therapies to reach the patients who need them.”
About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.
About The Korea Bioprocessing Excellence Awards
The Korea Bioprocessing Excellence Awards aims to recognize organizations within Korea that have engaged in substantial efforts to innovate, optimize processes and uphold a high level of efficacy, quality and safety in biological products manufacturing.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced it will create a new manufacturing and distribution Hub in Singapore, by integrating its existing distribution facility with new manufacturing operations. The new Hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year.
Avantor announced it will create a new Manufacturing and Distribution Hub in Singapore by integrating its existing distribution facility with new manufacturing operations.
“The Singapore Manufacturing and Distribution Hub will enable Avantor to better serve the fast-growing Asia Pacific Biopharma market by facilitating shorter lead times, enhancing supply chain security and increasing capacity in the region,” said Christophe Couturier, Executive Vice President, AMEA, Avantor. “The Hub will boost regional innovation and serve as an industry benchmark for Singapore and Asia Pacific’s global quality and regulatory standards, and demonstrates Avantor’s commitment to growing our presence in the region.”
The new Hub will provide a range of services including quality control and inventory management expertise, and feature cGMP manufacturing suites and testing labs for process ingredients and excipients.
About Avantor
Avantor, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.
